Abstract Embargo Policies

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

 ACR Convergence 2020 – All-Virtual Annual Meeting

ACR Convergence 2020, the world’s premier virtual rheumatology experience, is happening online, November 5-9.

Now, more than ever, the rheumatology community needs to maintain connection. ACR Convergence 2020 provides an opportunity to do just that. This fully virtual meeting is where rheumatology can collaborate, celebrate, innovate, and learn!

Get ready for an all-encompassing, all-virtual experience designed for the global rheumatology community. Get ready for ACR Convergence 2020.

We’ve given the ACR’s annual meeting a new name and a fresh look, and reimagined #ACR20 without losing the elements you care about most: stellar rheumatology education and outstanding networking opportunities.

We will be sharing abstract embargo policy details in the coming weeks and months, and we promise to keep you fully informed.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until 2:00 PM ET on November 5. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at abstracts@rheumatology.org.

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.

© 2020 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us